Find Federal Grants
BRAIN Initiative: Next-Generation Invasive Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 - Clinical Trial Required)
National Institutes of Health · RFA-NS-18-021
Improving Implementation of Seek, Test, Treat and Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01-Clinical Trial Required)
National Institutes of Health · RFA-DA-18-017
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44) - Clinical Trial Optional
National Institutes of Health · PAR-18-541
International Research Scientist Development Award (IRSDA) (K01) - Independent Clinical Trial Not Allowed
National Institutes of Health · PAR-18-539
Research on the Mechanisms and/or Behavioral Outcomes of Multisensory Processing (R01 - Clinical Trial Optional)
National Institutes of Health · PA-18-545
Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional)
National Institutes of Health · PAR-18-530
Early-life Factors and Cancer Development Later in Life (R01 - Clinical Trial Not Allowed)
National Institutes of Health · PA-18-529
Early-life Factors and Cancer Development Later in Life (R21 - Clinical Trial Not Allowed)
National Institutes of Health · PA-18-532
National Park Service · P18AS00046
Early-life Factors and Cancer Development Later in Life (R03 - Clinical Trial Not Allowed)
National Institutes of Health · PA-18-531
GLNF-CESU: Pilot Study Evaluating the Relationship of Community Gravel Beds and Developing Sustainable Tree Canopies- MWRO
National Park Service · NPS-NOIP18AC00073
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp - Clinical Trial Not Allowed)
National Institutes of Health · PA-18-517
National Institutes of Health · PA-18-376
National Institutes of Health · PA-18-474
National Institutes of Health · PA-18-475
National Institutes of Health · PA-18-377
Biobehavioral and Technological Interventions to Attenuate Cognitive Decline in Individuals with Cognitive Impairment or Dementia (R01 Clinical Trial Optional)
National Institutes of Health · PA-18-348
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R01 )
National Institutes of Health · PAR-18-510
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R03 Clinical Trial Optional)
National Institutes of Health · PAR-18-527
Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (R21 Clinical Trial Optional )
National Institutes of Health · PAR-18-509